Halozyme Therapeutics, Inc.
HALO
Revenue
264.86M
▼-33.15M▼-11.12%
3 Months ChangeAssets
2.20B
▲133.06M▲6.45%
3 Months ChangeLiabilities
1.71B
▲14.61M▲0.8594%
3 Months ChangeFree Cash Flow
153.27M
▲27.39M▲21.76%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001159036-24-000050
2024-10-31
Form 8-K
ID: 0001159036-24-000049
2024-08-06
Form 10-Q
ID: 0001159036-24-000044
2024-08-06
Form 8-K
ID: 0001159036-24-000043
2024-05-07
Form 10-Q
ID: 0001159036-24-000037
2024-05-07
Form 8-K
ID: 0001159036-24-000036
2024-04-26
Form 8-K
ID: 0001159036-24-000031
2024-02-20
Form 8-K
ID: 0001159036-24-000007
2024-01-17
Form 8-K
ID: 0001159036-24-000003
2023-11-06
Form 10-Q
ID: 0001159036-23-000057